About ekso bionics holdings - EKSO
Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following segments: EksoHealth and EksoWorks. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.
EKSO At a Glance
Ekso Bionics Holdings, Inc.
101 Glacier Point
San Rafael, California 94901
| Phone | 1-510-984-1761 | Revenue | 18.28M | |
| Industry | Medical Specialties | Net Income | -15,198,000.00 | |
| Sector | Health Technology | 2023 Sales Growth | 41.566% | |
| Fiscal Year-end | 12 / 2024 | Employees | 70 | |
| View SEC Filings |
EKSO Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 1.897 |
| Price to Book Ratio | 2.945 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -2.475 |
| Enterprise Value to Sales | 1.816 |
| Total Debt to Enterprise Value | 0.216 |
EKSO Efficiency
| Revenue/Employee | 261,128.571 |
| Income Per Employee | -217,114.286 |
| Receivables Turnover | 3.238 |
| Total Asset Turnover | 0.524 |
EKSO Liquidity
| Current Ratio | 2.49 |
| Quick Ratio | 1.867 |
| Cash Ratio | 1.064 |
EKSO Profitability
| Gross Margin | 53.055 |
| Operating Margin | -82.674 |
| Pretax Margin | -83.145 |
| Net Margin | -83.145 |
| Return on Assets | -43.534 |
| Return on Equity | -79.889 |
| Return on Total Capital | -76.859 |
| Return on Invested Capital | -62.728 |
EKSO Capital Structure
| Total Debt to Total Equity | 56.862 |
| Total Debt to Total Capital | 36.25 |
| Total Debt to Total Assets | 24.787 |
| Long-Term Debt to Equity | 44.066 |
| Long-Term Debt to Total Capital | 28.092 |